- Report
- October 2024
- 187 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2021
- 420 Pages
United States
From €2184EUR$2,400USD£1,873GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Book
- February 2024
- 592 Pages
Tranylcypromine is a drug used to treat mental disorders such as depression, anxiety, and bipolar disorder. It is a monoamine oxidase inhibitor (MAOI) that works by increasing the levels of certain neurotransmitters in the brain, such as serotonin and norepinephrine. Tranylcypromine is usually prescribed when other treatments, such as selective serotonin reuptake inhibitors (SSRIs), have not been effective. It is generally taken in tablet form, although it can also be administered as an injection.
Tranylcypromine is a prescription-only medication and is available in generic and brand-name forms. Common side effects include insomnia, dizziness, and dry mouth. It is important to note that tranylcypromine can interact with certain foods and medications, so it is important to discuss any potential interactions with a doctor before taking the drug.
Some companies in the tranylcypromine market include Pfizer, Mylan, and Teva Pharmaceuticals. Show Less Read more